Unleash develops immunotherapies for cancer treatment based in oncolytic viruses.

For more information, visit Unleash Immuno Oncolytics or follow their updates on:

Unleash Immuno Oncolytics Articles

BioGenerator

Local Immunotherapy Startup Attracts $3 Million Investment

mm
EQ Staff, Jonathan Allen
2 Min Read

Loading

-
313
Visitors